Ipca Laboratories (IPCALAB.NS) Financial Analysis & Valuation | Quarter Chart

Ipca Laboratories (IPCALAB.NS)

IPCALAB.NS
Price: $16.9
Fair Value: 🔒
🔒score
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides gene... more
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceut... more
Description Shares
Market Cap$4.29BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOPranay Premchand Godha
IPO Date1996-01-01CAGR0.14%
Employees17,335Websitewww.ipca.com
Div. Yield1.6%Payout Ratio—
Buy Back Yield—Total Yield1.6%
IPCALAB.NS chart loading...
Fundamentals Technicals
Enterprise Value$350.40BP/E Ratio43.43
Forward P/E28.85PEG Ratio1.85
P/S Ratio0.66P/B Ratio0.84
P/CF Ratio—P/FCF Ratio—
EPS$0.39EPS Growth 1Y25.74%
EPS Growth 3Y35.45%EPS Growth 5Y-16.53%
Revenue Growth 1Y9.66%Gross Margin0.66%
Operating Margin0.33%Profit Margin0.09%
ROE0.11%ROA0.07%
ROCE0.32%Current Ratio2.46
Quick Ratio1.47Cash Ratio0.08
Debt/Equity0.17Interest Coverage41
Altman Z Score7.96Piotroski Score6

View Ipca Laboratories financial charts →